ZBH PEER ANALYSIS

Zimmer Biomet Holdings Inc — metric-by-metric comparison with peers and the industry median

ZBHZimmer Biomet Holdings Inc

🇺🇸 USA · US · Healthcare · Medical Devices

Value it Duel

Overall Profile & Returns

· Medical Devices

Position Within Industry

0 = weak quartile, 100 = strong quartile

ZBHIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	ZBH	PHIA	SHL	COH	4DX	Ind. Median
P/E	22.50	24.65	18.77●	23.72	—	27.44
P/B	1.35	2.10	2.16	4.23	-74.16●	2.48
EV/EBITDA	10.96	10.82●	11.97	14.87	—	15.23
P/S	2.04	1.36●	1.70	3.47	243.16	2.66

Financial Health
Metric	ZBH	PHIA	SHL	COH	4DX	Ind. Median
Current Ratio	1.73	1.32	1.10	2.46	6.57●	3.28
Debt/Equity	59.0%	71.1%	84.1%	22.1%	-22.6%●	44.7%
NetDebt/EBITDA	3.19	2.03	3.04	0.42●	0.71	0.82

Profitability
Metric	ZBH	PHIA	SHL	COH	4DX	Ind. Median
Net Margin	9.1%	5.5%	9.1%	14.6%●	-3,684.6%	-5.7%
ROE	6.1%	8.4%	11.4%	18.1%●	—	-8.6%
ROA	3.4%	3.6%	4.6%	12.4%●	-264.3%	-6.4%
EBITDA Margin	26.2%●	15.4%	19.1%	24.0%	-818.8%	5.2%

Growth + Dividend
Metric	ZBH	PHIA	SHL	COH	4DX	Ind. Median
Rev. Growth	9.2%●	-1.9%	-0.3%	2.0%	-26.0%	7.4%
NI Growth	-16.7%	160.1%●	0.3%	-6.8%	—	16.7%
Div. Yield	1.1%	3.5%	2.9%	3.6%●	—	1.1%
Payout	24.9%	33.8%	48.4%	81.5%	—	39.0%

Valuation
Metric	ZBH	STE	PEN	PODD	GMED	DXCM	Ind. Median
P/E	22.50	27.44	73.65	38.13	18.87●	30.14	27.44
P/B	1.35●	2.99	8.55	8.86	2.34	9.48	2.48
EV/EBITDA	10.96●	12.65	56.90	20.89	12.00	18.30	15.23
P/S	2.04●	3.62	8.66	3.98	3.57	5.82	2.66

Financial Health
Metric	ZBH	STE	PEN	PODD	GMED	DXCM	Ind. Median
Current Ratio	1.73	2.09	6.02●	2.49	4.56	1.95	3.28
Debt/Equity	59.0%	29.1%	14.7%	72.8%	2.4%●	46.8%	44.7%
NetDebt/EBITDA	3.19	0.90	-0.11	0.81	-0.58	-0.70●	0.82

Profitability
Metric	ZBH	STE	PEN	PODD	GMED	DXCM	Ind. Median
Net Margin	9.1%	13.2%	11.8%	10.4%	18.9%	19.3%●	-5.7%
ROE	6.1%	11.3%	12.7%	23.0%	13.3%	35.6%●	-8.6%
ROA	3.4%	7.5%	9.8%	9.3%	11.6%	13.9%●	-6.4%
EBITDA Margin	26.2%	30.8%●	15.2%	19.8%	28.4%	30.6%	5.2%

Growth + Dividend
Metric	ZBH	STE	PEN	PODD	GMED	DXCM	Ind. Median
Rev. Growth	9.2%	8.7%	17.3%	31.9%●	23.5%	16.1%	7.4%
NI Growth	-16.7%	27.3%	305.0%●	-24.7%	216.2%	73.8%	16.7%
Div. Yield	1.1%	1.2%●	—	—	—	—	1.1%
Payout	24.9%	30.9%	—	—	—	—	39.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on ZBH

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 2, 26. This content is for informational purposes only and is not investment advice.